Markston International’s Bristol-Myers Squibb BMY Stock Holding History

Markston International’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$203K	Sell	3,263 -14	-0.4%	-$821	0.2%	73
2021 Q3	$194K	Hold	3,277	–	–	0.18%	75
2021 Q2	$219K	Sell	3,277 -33,892	-91%	-$2.21M	0.13%	74
2021 Q1	$2.35M	Sell	37,169 -313	-0.8%	-$19.5K	0.26%	72
2020 Q4	$2.33M	Sell	37,482 -2,123	-5%	-$131K	0.27%	72
2020 Q3	$2.39M	Sell	39,605 -822	-2%	-$49.5K	0.3%	67
2020 Q2	$2.38M	Sell	40,427 -646	-2%	-$38.6K	0.28%	67
2020 Q1	$2.29M	Hold	41,073	–	–	0.32%	64
2019 Q4	$2.64M	Buy	+41,073	New	+$2.35M	0.27%	70

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Markston International's BMY Position: Q4 2021 in Review

Markston International reduced its Bristol-Myers Squibb (BMY) stake by 0.43% in Q4 2021, selling an estimated $821 and leaving 3,263 shares worth $203K. The position accounts for 0.2% of the portfolio, ranked #73.

Markston International first reported a position in BMY in Q4 2019 and has held it in 9 quarters since. The position peaked at $2.64M in Q4 2019. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

Markston International held 3,263 shares of Bristol-Myers Squibb worth $203K as of Q4 2021.
Markston International sold 14 Bristol-Myers Squibb shares in Q4 2021, an estimated $821.
Bristol-Myers Squibb made up 0.2% of Markston International's portfolio in Q4 2021, its #73 holding.
Markston International first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 9 quarters since.
Markston International's Bristol-Myers Squibb position peaked at $2.64M in Q4 2019.
2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Markston International's 13F filing for Q4 2021, filed 21 Jan 2022.